Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 16 to 80 Women only

Erector spinae block to lower opioid use after total abdominal hysterectomy

Official title: Opioid Sparing Effect of Erector Spinae Block in Patients Undergoing Total Abdominal Hysterectomy; A Randomized Control Trial

Run by Kulsoom International Hospital · NCT07178262 · Data updated 2026-11-12

This will test whether giving an erector spinae nerve block during general anesthesia can reduce opioid use for people having an elective total abdominal hysterectomy.

More Opioid Use trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages16 Years to 80 Years
SexWomen only
Enrollment60 (estimated)
SponsorKulsoom International Hospital
Academic / other
Locations1 site (Islamabad, Federal)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedOctober 30, 2025
Study endsOctober 30, 2025
Registry record updatedSeptember 17, 2025
Trial IDNCT07178262 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (ASA class I–III) scheduled for elective total abdominal hysterectomy who can consent and do not have chronic opioid use or other exclusion criteria.

Probably not a fit

Patients with chronic pain, active opioid misuse or addiction, allergy to local anesthetics, or BMI over 35 are excluded and unlikely to gain benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Total abdominal hysterectomy causes substantial postoperative pain and often requires high perioperative opioid doses, which can slow recovery due to nausea, vomiting, constipation, and respiratory depression. In this interventional Phase 4 protocol, participants undergoing elective total abdominal hysterectomy receive either an erector spinae plane (ESP) block with bupivacaine or a placebo block in the perioperative period. Opioid consumption after surgery, along with common opioid-related side effects and recovery measures, will be recorded and compared between groups. Eligible patients are adults classified as ASA I–III having elective procedures at the study hospital.

Why it matters

Potential benefit: If successful, the ESP block could reduce perioperative opioid use and related side effects, helping patients recover more comfortably after hysterectomy.

How similar studies have gone: Fascial plane blocks including ESP and related regional techniques have shown reductions in postoperative opioid use in several surgical settings, but evidence is still emerging and varies by procedure.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologists (ASA) class: I, II and III .
* Elective Hysterectomy under General Anesthesia.

Exclusion Criteria:

* Lack of consent
* Body mass index \>35 kg/m2
* Allergic to study medicine
* Opioid abuse or misuse disorder
* Chronic pain

Where it's running

  • Kulsoom Internation Hospital
    Islamabad, Federal, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.